Actemra SubQ coming up?































The new formulation used the Halozyme technology that opens the SubQ space and allows for rapid and complete absorption, negating the need for IV infusion. Only problem is that teh Baxter product using the sames tech. just was required to do additional Preclinical work to gain approval.

Roche is doing the same thing with Herceptin and MabThera